Results 161 to 170 of about 3,958,292 (318)

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

ESTABLISHMENT AND CHARACTERIZATION OF A CONTINUOUS MURINE UTERINE CERVIX CANCER CELL-LINE METASTATIC TO LYMPH-NODES AND LUNGS [PDF]

, 1987
GAO, J, LIU, Y, MAREEL, M, WANG, JX, QIAN, SS, CAI, YY, DONG, HY, DEBRUYNE, G, LI, BG   +8 more
core  

RETRACTED: Abdi et al. Duloxetine, an SNRI, Targets pSTAT3 Signaling: <i>In</i>-Silico, RNA-Seq and <i>In</i>-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 10432. [PDF]

Int J Mol Sci
Abdi SAH, Azhar G, Zhang X, Wei JY.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Antioxidant Capacity Alterations in Bangladeshi Underutilized Fruits: InsightsFrom In Vitro Gastrointestinal Digestion Studies. [PDF]

Int J Food Sci
Alam M, Mahmood S, Jahan N, Ove TA, Mozumder NHMR, Khatun H.   +5 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Carboxyhemoglobin and depletion of blood oxygen in sleeping elephant seals. [PDF]

J Comp Physiol B
Ponganis PJ, McDonald BI, Williams CL, Meir JU, Brown CV, Patrician A, Tremblay JC, Hindle AG, Pallin LJ, Kendall-Bar JM, McKnight JC, Costa DP, Williams TM, Ainslie PN.   +13 more
europepmc   +1 more source

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology, EarlyView.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer   +7 more
wiley   +1 more source

Studio sulla germinabilità in vitro di semi di Fraxinus angustifolia Vahl. [PDF]

, 2007
CHIANCONE, Benedetta, MAZZOLA, Pietro, GERMANA', Maria, PATRICOLO G, STUDIO SULLA GERMINABILITA' IN VITRO DI SEMI DI FRAXINUS ANGUSTIFOLIA VAHL   +4 more
core  

In Vitro Innovations [PDF]

Environmental Health Perspectives, 1995
openaire   +1 more source